CA2477005A1 - Use of substituted 3-phenyl-5-alkoxy-1,3,4-oxdiazole-2-one for producing medicaments that inhibit pancreatic lipase - Google Patents
Use of substituted 3-phenyl-5-alkoxy-1,3,4-oxdiazole-2-one for producing medicaments that inhibit pancreatic lipase Download PDFInfo
- Publication number
- CA2477005A1 CA2477005A1 CA002477005A CA2477005A CA2477005A1 CA 2477005 A1 CA2477005 A1 CA 2477005A1 CA 002477005 A CA002477005 A CA 002477005A CA 2477005 A CA2477005 A CA 2477005A CA 2477005 A1 CA2477005 A1 CA 2477005A1
- Authority
- CA
- Canada
- Prior art keywords
- alkyl
- substituted
- aryl
- phenyl
- halogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Nutrition Science (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10208986A DE10208986A1 (de) | 2002-02-28 | 2002-02-28 | Verwendung substituierter 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one zur Herstellung von Arzneimitteln mit hemmender Wirkung an der pankreatischen Lipase |
| DE10208986.8 | 2002-02-28 | ||
| PCT/EP2003/001560 WO2003072098A1 (de) | 2002-02-28 | 2003-02-17 | Verwendung substituierter 3-phenyl-5-alkoxy-1,3,4-oxdiazol-2-one zur herstellung von arzneimitteln mit hemmender wirkung an der pankreatischen lipase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2477005A1 true CA2477005A1 (en) | 2003-09-04 |
Family
ID=27740557
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002477005A Abandoned CA2477005A1 (en) | 2002-02-28 | 2003-02-17 | Use of substituted 3-phenyl-5-alkoxy-1,3,4-oxdiazole-2-one for producing medicaments that inhibit pancreatic lipase |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1482929A1 (xx) |
| JP (1) | JP2005519079A (xx) |
| KR (1) | KR20040101250A (xx) |
| CN (1) | CN1638766A (xx) |
| AR (1) | AR038702A1 (xx) |
| AU (1) | AU2003210292A1 (xx) |
| BR (1) | BR0308045A (xx) |
| CA (1) | CA2477005A1 (xx) |
| CO (1) | CO5611144A2 (xx) |
| DE (1) | DE10208986A1 (xx) |
| HR (1) | HRP20040783A2 (xx) |
| HU (1) | HUP0500093A2 (xx) |
| IL (1) | IL163719A0 (xx) |
| MA (1) | MA27173A1 (xx) |
| MX (1) | MXPA04007480A (xx) |
| NO (1) | NO20044091L (xx) |
| PL (1) | PL371310A1 (xx) |
| RU (1) | RU2004128932A (xx) |
| TW (1) | TW200400026A (xx) |
| WO (1) | WO2003072098A1 (xx) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1765327B1 (en) | 2004-06-17 | 2014-08-13 | Cytokinetics, Inc. | Compounds, compositions and methods |
| CA2585175A1 (en) | 2004-10-25 | 2006-05-04 | Solvay Pharmaceuticals Gmbh | Pharmaceutical compositions comprising cb1 cannabinoid receptor antagonists and potassium channel openers for the treatment of diabetes mellitus type i, obesity and related conditions |
| AR058347A1 (es) | 2005-12-15 | 2008-01-30 | Cytokinetics Inc | Entidades quimias composiciones y metodos |
| US7825120B2 (en) | 2005-12-15 | 2010-11-02 | Cytokinetics, Inc. | Certain substituted ((piperazin-1-ylmethyl)benzyl)ureas |
| WO2007078839A2 (en) | 2005-12-19 | 2007-07-12 | Cytokinetics, Inc. | Compounds, compositions and methods |
| TWI415607B (zh) * | 2007-12-25 | 2013-11-21 | Kissei Pharmaceutical | 新穎兒茶酚衍生物、含有其之醫藥組成物及該等之用途 |
| AR074978A1 (es) | 2008-12-23 | 2011-03-02 | Bial Portela & Ca Sa | 3-n-aril-1,3,4-oxadiazolonas 5-o-sustituidas para uso en el tratamiento del dolor y procedimiento de obtencion |
| CN103086859B (zh) * | 2011-11-08 | 2015-11-11 | 清华大学 | 2,4-二羟基-5,6-取代-1-卤代苯衍生物、其合成方法及其应用 |
| AU2018326396B2 (en) * | 2017-09-01 | 2023-10-26 | Falasca, Marco PROF | Synthetic derivatives of oleoyl-lysophosphatidylinositol (oleolyl-LPI) and uses thereof |
| CN109879839B (zh) * | 2019-03-12 | 2023-04-25 | 沈阳大学 | 6-哌嗪甲基-7-羟基苯并呋喃类化合物及其医药用途 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19942354A1 (de) * | 1999-09-04 | 2001-03-08 | Aventis Pharma Gmbh | Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one, ihre Herstellung und Verwendung in Arzneimitteln |
| BR0108974A (pt) * | 2000-03-07 | 2003-06-03 | Aventis Pharma Gmbh | 3-fenil-5-alcóxi-1,3,4-oxdiazol-2-onas substituìdas e seu uso para a inibição das lipases sensìveis a hormÈnios |
-
2002
- 2002-02-28 DE DE10208986A patent/DE10208986A1/de not_active Withdrawn
-
2003
- 2003-02-17 CA CA002477005A patent/CA2477005A1/en not_active Abandoned
- 2003-02-17 WO PCT/EP2003/001560 patent/WO2003072098A1/de not_active Application Discontinuation
- 2003-02-17 AU AU2003210292A patent/AU2003210292A1/en not_active Abandoned
- 2003-02-17 KR KR10-2004-7013470A patent/KR20040101250A/ko not_active Application Discontinuation
- 2003-02-17 IL IL16371903A patent/IL163719A0/xx unknown
- 2003-02-17 MX MXPA04007480A patent/MXPA04007480A/es unknown
- 2003-02-17 PL PL03371310A patent/PL371310A1/xx not_active Application Discontinuation
- 2003-02-17 EP EP03742942A patent/EP1482929A1/de not_active Withdrawn
- 2003-02-17 RU RU2004128932/15A patent/RU2004128932A/ru not_active Application Discontinuation
- 2003-02-17 HU HU0500093A patent/HUP0500093A2/hu unknown
- 2003-02-17 JP JP2003570844A patent/JP2005519079A/ja not_active Withdrawn
- 2003-02-17 BR BR0308045-5A patent/BR0308045A/pt not_active Application Discontinuation
- 2003-02-17 CN CNA038047675A patent/CN1638766A/zh active Pending
- 2003-02-26 AR ARP030100625A patent/AR038702A1/es unknown
- 2003-02-26 TW TW092103972A patent/TW200400026A/zh unknown
-
2004
- 2004-07-27 MA MA27804A patent/MA27173A1/fr unknown
- 2004-08-26 CO CO04083781A patent/CO5611144A2/es not_active Application Discontinuation
- 2004-08-27 HR HR20040783A patent/HRP20040783A2/hr not_active Application Discontinuation
- 2004-09-27 NO NO20044091A patent/NO20044091L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1638766A (zh) | 2005-07-13 |
| RU2004128932A (ru) | 2005-04-10 |
| AU2003210292A1 (en) | 2003-09-09 |
| HUP0500093A2 (hu) | 2005-04-28 |
| DE10208986A1 (de) | 2003-09-11 |
| HRP20040783A2 (en) | 2005-04-30 |
| MXPA04007480A (es) | 2004-11-10 |
| WO2003072098A1 (de) | 2003-09-04 |
| KR20040101250A (ko) | 2004-12-02 |
| TW200400026A (en) | 2004-01-01 |
| IL163719A0 (en) | 2005-12-18 |
| EP1482929A1 (de) | 2004-12-08 |
| CO5611144A2 (es) | 2006-02-28 |
| BR0308045A (pt) | 2004-12-21 |
| JP2005519079A (ja) | 2005-06-30 |
| AR038702A1 (es) | 2005-01-26 |
| MA27173A1 (fr) | 2005-01-03 |
| PL371310A1 (en) | 2005-06-13 |
| NO20044091L (no) | 2004-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7205296B2 (en) | Substituted 2H-1,3-benzoxazin-4(3H)-ones | |
| EP1024138B1 (en) | Pyrazole derivatives | |
| JP2008509982A (ja) | アリール尿素誘導体 | |
| US7528158B2 (en) | Indazolone derivatives useful as 11b-HSD1 inhibitors | |
| JP5913296B2 (ja) | ヘキサフルオロイソプロピルカルバマート誘導体、この調製およびこの治療的用途 | |
| US6369088B2 (en) | Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, their preparation and their use as pharmaceuticals | |
| MX2011000628A (es) | Derivados de heteroarilo como inhibidores de dgat1. | |
| EP1585727B1 (en) | Indoles useful in the treatment of androgen-receptor related diseases | |
| CA2477005A1 (en) | Use of substituted 3-phenyl-5-alkoxy-1,3,4-oxdiazole-2-one for producing medicaments that inhibit pancreatic lipase | |
| AU2009235406A1 (en) | Sulfonamides | |
| AU714701B2 (en) | Novel thiophene derivative and pharmaceutical composition thereof | |
| KR20170106470A (ko) | 치환된 트리아졸 및 이와 관련된 방법 | |
| US20030236288A1 (en) | Use of substituted 3-phenyl-5-alkoxy-3H-(1,3,4)-oxadizol-2-ones for inhibiting pancreatic lipase | |
| EP1874742A1 (en) | 3,4-dihydro-benzo[e][1,3]oxazin-2-ones | |
| AU2010207190A1 (en) | Benzodiazepin-2-on derivatives | |
| JP2007332034A (ja) | 複素環化合物 | |
| MXPA04007960A (es) | 3-fenil-5-alcoxi-1,3,4-oxadiazol-2-onas sustituidas, su produccion y su uso en medicamentos. | |
| KR20070086366A (ko) | 피페리딘설포닐우레아 및 피페리딘설포닐티오우레아,이들의 제조방법, 이들의 용도 및 이들을 포함하는약제학적 조성물 | |
| JP4198755B6 (ja) | アリールアルカノイルピリダジン誘導体 | |
| JP4198755B2 (ja) | アリールアルカノイルピリダジン誘導体 | |
| JP5297663B2 (ja) | 複素環化合物 | |
| CA2410628A1 (en) | Carbamic acid esters | |
| MXPA06008355A (en) | Triazole derivatives which inhibit vasopressin antagonistic activity | |
| CZ341799A3 (cs) | Deriváty hydroxamové kyseliny substituované aryl- nebo heteroarylsulfonamidem, způsob jejich přípravy a jejich použití jako léčivých přípravků |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |